Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Multicenter Phase I Dose Escalation and Expansion Study of Pyrotinib in Combination with Camrelizumab and Chemotherapy As First-Line Treatment for HER2-positive Advanced Gastric and Gastroesophageal Junction Adenocarcinoma.

Liangjun Zhu, Sheng Li,Jun Bao,Xiaoyou Li,Quanliang Yang,Junying Xu, Surong Chen, Ge Feng,Chao Gao, Lin Feng,Bin Lu, Min Miao,Xinchu Ni, Guofang Wang,Lei Yang

JOURNAL OF CLINICAL ONCOLOGY（2023）

Cited 1|Views13
Key words
Advanced gastric adenocarcinoma,Pyrotinib in combination with camrelizumab and chemotherapy,Phase 1 study,First-line therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined